Viewing Study NCT02212067


Ignite Creation Date: 2025-12-25 @ 12:45 AM
Ignite Modification Date: 2026-02-25 @ 5:45 PM
Study NCT ID: NCT02212067
Status: COMPLETED
Last Update Posted: 2018-03-07
First Post: 2014-08-07
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Trial Investigating the Effects of Semaglutide on ß-cell Function in Subjects With Type 2 Diabetes
Sponsor: Novo Nordisk A/S
Organization:

Organization Data

Organization:
Class: INDUSTRY
Study ID: NN9535-3635
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type: SPONSOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators